Overconsumption detected by electronic drug monitoring requires subtle interpretation

Clinical Pharmacology and Therapeutics

Volumn 67, Issue 1, 2000, Pages 44-47

  Arnet, Isabelle ^a   Haefeli, Walter ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN;

ARTICLE; CLINICAL ARTICLE; DRUG MONITORING; DRUG USE; ELECTRONICS; HUMAN; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT DISCHARGE; SELF ADMINISTRATION; VITAMINS;

EID: 0033950203     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.103821     Document Type: Article

References (5)

1. 1. Urquhart J, De Klerk E. Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens. Stat Med 1998;17:251-67.
2. 2. Kruse W, Nikolaus T, Rampmaier J, Weber E, Schlierf G. Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring. Eur J Clin Pharmacol 1993;45:211-5.
3. 3. Rudd P, Ahmed S, Zachary V, Barton C, Bonduelle D. Improved compliance measures: applications in an ambulatory hypertensive drug trial. Clin Pharmacol Ther 1990;48:676-85.
4. 4. Mallion JM, Dutrey-Dupagne C, Vaur L. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens 1996;14:137-44.
5. 5. Mallion JM, Meilhac B, Tremel F, Calvez R, Bertholom N. Use of a microprocessor-equipped tablet box in monitoring compliance with antihypertensive treatment. J Cardiovasc Pharmacol 1992;19(suppl 2):S41-8.